For the Inventor, By the Inventor

Enter assignee name

Burlington, MA, United States of America

Scpharmaceuticals Inc.

USPTO Granted Patents = 14

EPO Patents = 4

Trademarks = 5

Forward Citations = 33

Loading Chart...

Loading Chart...

9 inventors (with patents filed for the assignee):

Franciscus Koppenhagen (10 out of 13 patents)

Alfredo Grossi (7 out of 10 patents)

Britt Kostraba (7 out of 10 patents)

4. Shannon Terry (7 out of 10 patents)

5. Pieter Muntendam (4 out of 10 patents)

6. Scott A Michaels (4 out of 4 patents)

7. Olatokumbo O Luca Ogunleye (4 out of 4 patents)

8. Glenn R Larsen (4 out of 30 patents)

9. Olatokumbo Olajimi Luca Ogunleye (3 out of 6 patents)

10. Michael Hassman (0 patent)

11. John F Mohr, Iii (0 patent)

12. Erik Mark Pecorelli (0 patent)

13. Bhavini Patel (0 patent)

14. Phani Kamineni (0 patent)

15. John Tucker (0 patent)

14 patents: Sort by Forward Citations

1. 12491197 - Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same (2025-12-09),

2. 12491196 - Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same (2025-12-09),

3. 12491195 - Concentrated liquid pharmaceutical Formulations of furosemide and methods of administering the same (2025-12-09),

4. 12491194 - Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same (2025-12-09),

5. 12491193 - Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same (2025-12-09),

6. 12370168 - Pharmaceutical formulations for subcutaneous administration of furosemide (2025-07-29),

7. 12048709 - Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same (2024-07-30),

8. 11998555 - Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same (2024-06-04),

9. 11571434 - Concentrated liquid pharmaceutical formulations of furosemide (2023-02-07),

10. 11559535 - Concentrated liquid pharmaceutical formulations of furosemide (2023-01-24),

11. 11497755 - Concentrated liquid pharmaceutical formulations of furosemide (2022-11-15),

12. 11433044 - Pharmaceutical formulations for subcutaneous administration of furosemide (2022-09-06),

13. 10272064 - Pharmaceutical formulations for subcutaneous administration of furosemide (2019-04-30),

14. 9884039 - Pharmaceutical formulations for subcutaneous administration of furosemide (2018-02-06),

Scpharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing products in the cardiovascular and infectious disease markets. The company's lead product, Furoscix, is a subcutaneous formulation of furosemide in development for the treatment of congestion in patients with heart failure. Scpharmaceuticals is committed to improving patient outcomes through innovative therapies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

14 Patents

#41 in Burlington, MA

#1,315 in Massachusetts

#21,642 in US

#40,929 in the World

Burlington, MA, United States of America

Scpharmaceuticals Inc.

Forward Citations = 33

9 inventors:

Franciscus Koppenhagen (10 out of 13 patents)

Alfredo Grossi (7 out of 10 patents)

Britt Kostraba (7 out of 10 patents)

4. Shannon Terry (7 out of 10 patents)

5. Pieter Muntendam (4 out of 10 patents)

Please report any incorrect information to support@idiyas.com

Loading…